May 26, 2010
A month ago I was able to sit down with FDA's Deputy Commissioner Dr. Joshua Sharfstein to discuss the FDA's new effort at transparency and accountability called FDA Tracker, resulting in a podcast on the subject. FDA Tracker is a … Continue reading →
May 27, 2008
No doubt the latest report from the Federal Trade Commission (FTC) Bureau of Competition is going to set the hair of several congresspeople on fire and will perhaps result in a hearing on the matter. The subject of the report … Continue reading →
May 3, 2007
Yesterday the FDA issued a news release that was entitled the "Critical Path Opportunities for Generic Drugs" that raises more than a few interesting points. First, it has been a long time since we’ve heard much about the FDA’s Critical … Continue reading →
October 24, 2006
Lately the environment for generic drugs has grown much warmer. Consider, last week the FDA/CDER proposed a speedier process for considering approval of generics. Walmart, one of the biggest retail chains in the country, announced it would sell many generics … Continue reading →
August 15, 2006
TORONTO, ONTARIO – On the first full day of the XVI International AIDS Conference, a panel was held of two distinguished men named Bill – one was Bill Gates and the other was Bill Clinton. For an hour and a … Continue reading →